Broker snap: Jefferies downgrades asset managers Schroders, Henderson and Jupiter
5th Apr 2013 09:51
Jefferies has downgraded its ratings for three asset managers, Schroders, Henderson and Jupiter, in a review of the sector following the strong equity markets and re-ratings seen so far this year. Unsurprisingly, given the year-to-date stock-market surge year seen across the globe, Jefferies says t
Read moreWednesday share tips: Man Group, Interserve
3rd Apr 2013 07:15
Support services firm Interserve´s share price has had a very good run year-to-date, on the back of a full order book. Particularly worth noting is the fact that it grew at a time when some of its peers were seeing a contraction. As well, there is still room for new wins, as with yesterday´s contrac
Read moreTuesday newspaper round-up: Citigroup, RBS, easyJet...
19th Mar 2013 06:51
US banking giant Citigroup is to pay 730m dollars to settle claims about allegedly misleading investors over its exposure to subprime mortgages between 2006 and 2008, reports the Financial Times. The paper says that this is the second-biggest class action payout in relation to the financial crisis.
Read moreTuesday broker round-up UPDATE
12th Mar 2013 07:19
Abcam:Investec shifts target price from 484p to 487p and keeps a buy recommendation. Admiral Group: UBS ups target price from 1200p to 1275p and reiterates a neutral rating. Amlin: Westhouse Securities raises target price from 440p to 455p, but downgrades from add to neutral. Anite: Numis reduce
Read moreWednesday broker round-up UPDATE
6th Mar 2013 07:03
Advanced Medical Solutions: Investec takes target price from 68p to 74p and maintains a buy recommendation. Aggreko: Citigroup reduces target price from 2550p to 2100p, while keeping a buy rating. Ashtead Group: Citigroup raises target price from 590p to 660p leaving its buy recommendation unalter
Read moreTuesday broker round-up UPDATE
5th Mar 2013 07:15
Abcam: Investec raises target price from 466p to 484p and keeps a buy recommendation. Numis revises target price from 470p to 530p and maintains its buy ratng. Access Intelligence: Merchant Securities initiates with a target price of 7p and a buy recommendation. Amlin: Canaccord Genuity raises tar
Read moreLondon close: Strong US data prompts late rally...again
1st Mar 2013 17:13
For a third day in a row, the FTSE 100 index rallied in afternoon trade on the back of strong economic figures from America, as investors temporarily shrugged off concerns about the automatic spending cuts which kick in later today. US President Barack Obama met with congressional leaders this afte
Read moreFTSE 250 movers: Hikma soars on 'unsolicited enquiries'
1st Mar 2013 15:23
Hikma Pharmaceuticals on Friday confirmed that it has received several unsolicited enquiries in its Injectables business and is now undertaking a review of strategic options for its future, prompting a strong rise in the share price. High Street betting shop William Hill jumped after announcing th
Read moreLondon midday: Risk appetite declines as US budget cuts loom
1st Mar 2013 12:04
After an initial stint in positive territory, UK stock markets swung sharply into the red by Friday lunchtime as concerns about budget cuts in the US take their toll on risk appetite. Sequestration is continuing to dominate headlines this morning as the deadline for across-the-board automatic budge
Read moreBroker tips: Lloyds, Man Group, William Hill
1st Mar 2013 11:48
Canaccord Genuity has retained its 'hold' rating and 35p target price for UK banking group Lloyds after a mixed set of full-year results on Friday morning. As for the stock's valuation, Canaccord said that unless the regulator allows an earlier resumption of ordinary dividend - something that is li
Read moreBroker snap: UBS downgrades Man Group to 'neutral'
1st Mar 2013 09:36
UBS said it is 'waiting for more visibility' on key stock drivers at Man Group as it downgraded the asset manager from 'buy' to 'neutral' on Friday morning. "Management delivered a strong presentation [on Thursday] highlighting the company's strong competitive advantages such as an embedded distrib
Read moreFriday broker round-up UPDATE
1st Mar 2013 07:17
Ashtead Group: Citigroup increases target price from 487p to 590p and keeps a buy recommendation. Atkins: JP Morgan raises target price from 893p 920p, reiterating an overweight rating. Berendsen: Panmure Gordon moves target price from 582p to 760p, while staying with its hold recommendation. Cant
Read moreMan Group confirms GLG analyst being questioned by FSA
28th Feb 2013 09:45
An analyst from GLG, which is owned by alternative asset manager Man Group, has been arrested by the Financial Services Authority (FSA) and the Metropolitan Police. In a statement issued on Wednesday, the FSA, reported that it had executed six search warrants in the City of London and Greater Londo
Read moreAdjusted profits edge higher at Man Group
28th Feb 2013 08:45
Adjusted profit before tax (PBT) rose to 278m dollars in the full year to December 31st from 262m dollars in the nine months to December 31st 2011 at Man Group. The FTSE 100-listed alternative asset manager reported that funds under management at the end of 2012 were $57bn compared to $58.4bn in th
Read moreTuesday broker round-up UPDATE
19th Feb 2013 07:30
Admiral Group: Investec takes target price from 570p to 582p, but still recommends selling. Advanced Medical Solutions: Investec upgrades from hold to buy with a target price of 68p. African Barrick Gold: Canaccord Genuity reduces target price from 360p to 305p keeping a hold rating. Anglo Americ
Read more